What We're Reading: Page 146
Industry reads hand-picked by our editors
Jul 09, 2021
Jul 08, 2021
-
Axios
The drug pricing lawsuit that could blow up Medicare
-
The Wall Street Journal
Theranos Founder Elizabeth Holmes Renews Fight to Constrain Prosecutors
-
NBC News
Pharma giant's policy change will devastate local HIV-prevention clinics' efforts
-
Fierce Biotech
Eli Lilly taps Verge Genomics in ALS deal worth $25M upfront
Jul 07, 2021
-
Bloomberg
When Lifesaving Vaccines Become Profit Machines for Drugmakers
-
The Washington Post
The controversial approval of an Alzheimer’s drug reignites the battle over the underlying cause of the disease
-
The Wall Street Journal
Covid-19 Vaccine-Related Blood Clots Linked to Amino Acids in New Study
-
Reuters
Novartis to make Leqvio for U.S. in Austria to overcome FDA delay
Jul 06, 2021
-
Axios
Physicians will feel pressure as gatekeepers of Aduhelm
-
The Wall Street Journal
Midsize Pharmaceutical Firms Are the Industry's Big Deal Makers This Year
-
Endpoints News
Bob Nelsen is building a really big neuroscience company
-
Evaluate Vantage
Biopharma takeovers dry up
Jul 02, 2021
-
The Atlantic
The Danger of Delta Holds to 3 Simple Rules
-
Reuters
Novartis weighs entry into mRNA technology, chairman tells paper
-
The Wall Street Journal
GlaxoSmithKline Says Board Supports Under-Pressure CEO
-
Science
Scientists quit journal board, protesting ‘grossly irresponsible’ study claiming COVID-19 vaccines kill
Jul 01, 2021
Jun 30, 2021
-
The New York Times
Mixing Pfizer, AstraZeneca Vaccines Gives Strong Covid Protection, Study Finds
-
Kaiser Health News
States Step Up Push to Regulate Pharmacy Drug Brokers
-
The Wall Street Journal
Why Vaccinated Athletes Are Testing Positive for Coronavirus
Previous
